SUN-042 PREGNANE X RECEPTOR (PXR) IS A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF CISPLATIN-INDUCED NEPHROTOXICITY IN MICE

Z. LUAN,X. Huo,W. Ming,X. Sun,C. Du,Z. Luo,Y. Zhou,Y. He,L. Chen,X. Zhang,Y. Guan
DOI: https://doi.org/10.1016/j.ekir.2020.02.565
IF: 6.234
2020-01-01
Kidney International Reports
Abstract:As a widely used chemotherapeutic agent for treating malignancies, the clinical application of cisplatin (CP) is limited by the toxicity to several vital human organs, especially nephrotoxicity. The pregnane X receptor (PXR) is a ligand-dependent transcriptional factor belonging to the nuclear receptor superfamily. PXR is highly expressed in the liver, intestine and kidney, where it plays an important role in xenobiotic and endobiotic metabolism. PXR is constitutively expressed in normal kidney with relatively high levels in the proximal tubular cells, which are initially affected in CP-induced nephrotoxicity.
What problem does this paper attempt to address?